External Lecturer, Department of Pharmacy, University of Copenhagen and Regulatory Affairs senior RA CMC specialist
Nykode Therapeutics.
The EU Regulatory Environment - Procedures and Applications
This course addresses the current and practical aspects of getting medicines approved in the EU.
This course is a part of
Understand the EU regulatory framework and the various types of marketing authorisation applications (MAAs) for new medicinal products, generic and similar biological medicinal products, line extensions, variation applications and renewals.
After completion the student will be able to navigate in the approval procedures and requirements for medicines in the EU, seek scientific advice from authorities and suggest and discuss reasonable pathways for obtaining approval for medicines in the EU, i.e. what is required of an marketing authorisation application.
Course content
The student will obtain knowledge of the EU pharmaceutical legislation, the content of a marketing authorisation application (MAA), EU approval procedures, scientific advice from CHMP and national authorities, paediatric investigation plan, and orphan products, and Risk Management Plans.
The lectures will be held by leading experts from industry and from health authorities. The theoretical exercises will be held as group work exercises where both procedural as well as strategic aspects will be discussed.
For more details about the course, please refer to the course curriculum.
Course directors on »The EU Regulatory Environment - Procedures and Applications«
Eva Maiken Holck
Course details for »The EU Regulatory Environment - Procedures and Applications«
Dates and examination
Course dates
4–6 March 2026
The course is available every other year.
Examination
Please find the exam dates in the exam plan.
Learning outcomes
This course offers a comprehensive overview of the process for obtaining medicine approval in the EU, covering key EU pharmaceutical legislation, guidelines, and the requirements for a marketing authorisation application (MAA). It also includes insights into scientific advice from EMA committees, pharmacovigilance, paediatrics, and orphan medicinal products. Students will gain the skills to navigate EU approval procedures, seek scientific advice, and recommend appropriate pathways for obtaining medicine approval in the EU.
On completion of the course, you will be able to:
-
understand and discuss the EU regulatory framework, including various types of marketing authorisation applications (new products, generics, line extensions, variations, and renewals)
-
comprehend the Centralised Procedure (CP) and Mutual Recognition/Decentralised Procedures (MRP/DCP) for obtaining approval in the EU
-
explain on clinical trial applications, scientific advice procedures, orphan medicinal product designation, and paediatric investigation plans
-
analyse and evaluate requirements for a Marketing Authorisation Application (MAA) and risk management plans
-
develop strategic regulatory plans, lead international teams, and advise on the impact of EU and international legislation and guidelines (EMA, ICH).
Admission criteria
You must meet the following criteria to be admitted to this course:
- Hold a relevant bachelor degree or equivalent.
- Have a minimum 2 years of relevant job experience.
- Be proficient in English.
Find detailed information in the admission criteria on Master of Medicines Regulatory Affairs.
You will receive a response to your application at the earliest on 1 May and no later than 2 weeks after the application deadline.
Priority is given to enrolled students
This course is offered as a compulsory course in the Master of Medicines Regulatory Affairs programme. Priority is given to students already enrolled. Once the enrolled students have been admitted to the course, the remaining seats are distributed on a first-come, first-served basis.
Partnership with Atrium
Atrium is a partner of Master of Medicines Regulatory Affairs. This course is one of 5 courses at the Master's programme, which are offered in collaboration with Atrium.
Atrium is one of Europe’s leading private course providers of practice-based courses in Regulatory Affairs. Their courses are based on collaboration with academia, industry experts and representatives from healthcare authorities.
International educational academy
Atrium is an international educational academy established by The Danish Association of the Pharmaceutical Industry (Lif). As a part of the Danish Association of the Pharmaceutical Industries, Atrium has a close connection to the experts in the Pharmaceutical Industry.
Tuition fees
EU/EEA citizens
Master student: 21,401 DKK
Single course: 23,401 DKK
Non-EU/EEA citizens
Master student: 23,801 DKK
Single course: 25,801 DKK
The fee includes lunch and coffee.
More information
All course information is available in the course curriculum:Location
Faculty of Health and Medical Sciences
Department of Pharmacy and Department of Drug Design and Pharmacology
Atrium, Lersø Parkallé 101
DK-2100 Copenhagen Ø
